1. Home
  2. FHTX vs BYM Comparison

FHTX vs BYM Comparison

Compare FHTX & BYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FHTX
  • BYM
  • Stock Information
  • Founded
  • FHTX 2015
  • BYM 2002
  • Country
  • FHTX United States
  • BYM United States
  • Employees
  • FHTX N/A
  • BYM N/A
  • Industry
  • FHTX Medicinal Chemicals and Botanical Products
  • BYM Investment Managers
  • Sector
  • FHTX Health Care
  • BYM Finance
  • Exchange
  • FHTX Nasdaq
  • BYM Nasdaq
  • Market Cap
  • FHTX 278.1M
  • BYM 271.5M
  • IPO Year
  • FHTX 2020
  • BYM N/A
  • Fundamental
  • Price
  • FHTX $4.89
  • BYM $10.57
  • Analyst Decision
  • FHTX Strong Buy
  • BYM
  • Analyst Count
  • FHTX 8
  • BYM 0
  • Target Price
  • FHTX $12.63
  • BYM N/A
  • AVG Volume (30 Days)
  • FHTX 118.7K
  • BYM 60.2K
  • Earning Date
  • FHTX 08-05-2025
  • BYM 01-01-0001
  • Dividend Yield
  • FHTX N/A
  • BYM 4.49%
  • EPS Growth
  • FHTX N/A
  • BYM N/A
  • EPS
  • FHTX N/A
  • BYM N/A
  • Revenue
  • FHTX $24,173,000.00
  • BYM N/A
  • Revenue This Year
  • FHTX $33.60
  • BYM N/A
  • Revenue Next Year
  • FHTX $5.87
  • BYM N/A
  • P/E Ratio
  • FHTX N/A
  • BYM N/A
  • Revenue Growth
  • FHTX N/A
  • BYM N/A
  • 52 Week Low
  • FHTX $2.95
  • BYM $9.30
  • 52 Week High
  • FHTX $10.25
  • BYM $11.77
  • Technical
  • Relative Strength Index (RSI)
  • FHTX 42.08
  • BYM 61.26
  • Support Level
  • FHTX $4.72
  • BYM $10.38
  • Resistance Level
  • FHTX $5.24
  • BYM $10.56
  • Average True Range (ATR)
  • FHTX 0.41
  • BYM 0.12
  • MACD
  • FHTX -0.16
  • BYM 0.03
  • Stochastic Oscillator
  • FHTX 13.73
  • BYM 76.09

About FHTX Foghorn Therapeutics Inc.

Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.

About BYM Blackrock Municipal Income Quality Trust of Beneficial Interest

Blackrock Municipal Income Quality Trust is a closed-end municipal bond fund. Its investment objective is to provide current income exempt from U.S. federal income taxes, including the alternative minimum tax. The trust invests in various sectors such as transportation, utilities, health, education, corporate, housing, and others.

Share on Social Networks: